Abstract
Background and purpose: The aim of this study was to quantify and characterise the mechanism of non-neuronal acetylcholine (ACh) release from bladder urothelial cells and to determine if urothelial cells could be a site of action of anti-muscarinic drugs.
Experimental approach: A novel technique was developed whereby ACh could be measured from freshly isolated guinea-pig urothelial cells in suspension following mechanical stimulation. Various agents were used to manipulate possible ACh-release pathways in turn and to study the effects of muscarinic receptor activation and inhibition on urothelial ATP release.
Key results: Minimal mechanical stimulus achieved full ACh release, indicating a small dynamic range and possible all-or-none signal. ACh release involved a mechanism dependent on CFTR and intracellular calcium concentration, but was independent of extracellular calcium, vesicular trafficking, connexins or pannexins, organic cation transporters and was not affected by botulinum-A toxin. Stimulating ACh receptors increased ATP production and antagonising them reduced ATP release, suggesting a link between ACh and ATP release.
Conclusions and implications: These results suggest that non-neuronal ACh release from the urothelium is large enough and well located to act as a modulator of ATP release. It is hypothesised that this pathway may contribute to the actions of antimuscarinic drugs in reducing the symptoms of lower urinary tract syndromes. Additionally an involvement of CFTR in ACh release suggests an exciting new direction for the treatment of these conditions.
Experimental approach: A novel technique was developed whereby ACh could be measured from freshly isolated guinea-pig urothelial cells in suspension following mechanical stimulation. Various agents were used to manipulate possible ACh-release pathways in turn and to study the effects of muscarinic receptor activation and inhibition on urothelial ATP release.
Key results: Minimal mechanical stimulus achieved full ACh release, indicating a small dynamic range and possible all-or-none signal. ACh release involved a mechanism dependent on CFTR and intracellular calcium concentration, but was independent of extracellular calcium, vesicular trafficking, connexins or pannexins, organic cation transporters and was not affected by botulinum-A toxin. Stimulating ACh receptors increased ATP production and antagonising them reduced ATP release, suggesting a link between ACh and ATP release.
Conclusions and implications: These results suggest that non-neuronal ACh release from the urothelium is large enough and well located to act as a modulator of ATP release. It is hypothesised that this pathway may contribute to the actions of antimuscarinic drugs in reducing the symptoms of lower urinary tract syndromes. Additionally an involvement of CFTR in ACh release suggests an exciting new direction for the treatment of these conditions.
Original language | English |
---|---|
Pages (from-to) | 3394-3403 |
Number of pages | 10 |
Journal | British Journal of Pharmacology |
Volume | 171 |
Issue number | 14 |
Early online date | 25 Jun 2014 |
DOIs | |
Publication status | Published - 1 Jul 2014 |